207_Combined course Presentations

Enrollment in Therapeutic Trials

% profiled enrolled on trials

% profiled enrolled on genotype matched trials

Patients Accrued

Patients Profiled

Tumor Type

20% 13% 16% 13%

5% 6% 7% 6% 1% 2% 5% 2% 5%

430 341 339 326 151

405 319 256 299 104

Gynecological

Breast

Lung

Colorectal

9%

Pancreatobiliary Upper Aerodigestive Genitourinary

115

102

8%

12% 21% 15%

92 99

74 81

Other Totals

1893

1640

*median follow-up 18 months

P. Bedard et al. AACR 2015